Trial Profile
Efficacy of zoledronic acid for the prevention of glucocorticoid therapy-associated bone loss in patients with acute flare of Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2011
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Bone resorption; Osteoporosis
- Focus Therapeutic Use
- 11 Apr 2011 New trial record
- 08 Mar 2011 Results published in the American Journal of Gastroenterology.